Fosun Kite Biotechnology
https://www.fosunkitebio.com/Overview
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 24, 2021 | China's first CAR-T Cell Therapy approved-Fosun Kite Axicabtagene Ciloleucel (FKC876) | The first* CAR-T cell therapy approved by NMPA: opening a new era of cell therapy in China Individualized living-cell-based medicine: genetically modify patient's T-cells to expresses a chimeric antigen receptor (CAR) that will activate T-c... |
| Fosun Kite Biotechnology | “复星凯特特-Focus on healing point bright life” |
Reviews 0
FAQ about Fosun Kite Biotechnology
When was Fosun Kite Biotechnology founded?
Fosun Kite Biotechnology was founded in 2017.
What has the press written about Fosun Kite Biotechnology?
Parsers VC has collected 3 articles mentioning Fosun Kite Biotechnology, among them “China's first CAR-T Cell Therapy approved-Fosun Kite Axicabtagene Ciloleucel (FKC876)” (Jun 24, 2021) and “Fosun Kite Biotechnology”.
Is Fosun Kite Biotechnology still active?
Fosun Kite Biotechnology is probably closed: its latest activity on Parsers VC dates from Oct 28, 2022.